TEL AVIV, Israel,
November 13, 2012 /PRNewswire/ --
Additional activities include demonstrating
WISHPro® and its immediate Anti- Aging and Rejuvenation results.
Synoia Technologies, the fastest growing medical aesthetics devices manufacturer, is excited to announce the launch of 3 new infusion capsules for the WishPro® system, best known for its ability to deliver immediate anti-aging and rejuvenation results.
At CosmoProf Asia, taking place
, Synoia will introduce 3 new infusion treatments for
at booth 3E-K4D.
The new BTX infusion with Acetyl hexapeptide-8 (Argireline®) is specially engineered as a topical treatment that mimics the effects of BOTOX® in the skin without any side effects.
The new Collagen Infusion protects the skin and fights free radicals to slow down skin aging and cell degradation. The infusion contains a special kind of Beta carotene which is significantly stronger in antioxidant activity and repairs DNA.
The third innovative infusion launched contains Hyaluronic Acid that stimulates Collagen and Elastin syntheses, and increases the skins capacity to hold water keeping the skin nourished, moist and healthy.
The new infusions to be launched are designed for
, the revolutionary aesthetics device launched last year that has become famous for its ability to deliver instant visible results and significantly reduce fine lines and wrinkles in just 15 minutes.
WISHPro® comes with 4 different technology heads cleverly fitting the ideal and proven technological solution to any skin problem.
2 world patents and an innovative business model enabling immediate ROI have made WISHPro® a very popular device for upgrading any salon or spa.
The ability of Synoia to always develop new technology heads and introduce new infusion capsules like the ones currently introduced have positioned Synoia as one of the leading aesthetic devices companies.
Check Out Our Best Services for Investors
Jim Cramer and Stephanie Link reveal their investment tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
Jim Cramer's protégé, David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts